OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline XWELL Q3 2023 Earnings Miss on Deeply Negative EPS Sends Stock Lower Ziff Davis Q1 2026 Earnings EPS Misses Estimates Stock Rises 475 ARE Q1 2026 Earnings Massive EPS Surprise of 1459 Drives Positive Stock Reaction NRXP Q1 2026 Earnings Revenueless Biotech Reports EPS Miss but Stock Surges 34 SHLS Q1 2026 Earnings EPS Beats Estimates by 10 Amid Strong Operational Performance